| Aluminium toxicokinetics: an updated minireview RA Yokel, PJ McNamara Pharmacology & Toxicology: MiniReview 88 (4), 159-167, 2001 | 492 | 2001 |
| Ontogeny of hepatic and renal systemic clearance pathways in infants part I J Alcorn, PJ McNamara Clinical pharmacokinetics 41, 959-998, 2002 | 322 | 2002 |
| Pharmacokinetics in the newborn J Alcorn, PJ McNamara Advanced drug delivery reviews 55 (5), 667-686, 2003 | 311 | 2003 |
| Effects of concentration‐dependent plasma protein binding on ceftriaxone kinetics K Stoeckel, PJ McNamara, R Brandt, H Plozza‐Nottebrock, WH Ziegler Clinical Pharmacology & Therapeutics 29 (5), 650-657, 1981 | 236 | 1981 |
| Protein binding predictions in infants PJ McNamara, J Alcorn Aaps Pharmsci 4, 19-26, 2002 | 225 | 2002 |
| Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction J Alcorn, X Lu, JA Moscow, PJ McNamara Journal of Pharmacology and Experimental Therapeutics 303 (2), 487-496, 2002 | 185 | 2002 |
| Ontogeny of hepatic and renal systemic clearance pathways in infants: part II J Alcorn, PJ McNamara Clinical pharmacokinetics 41, 1077-1094, 2002 | 183 | 2002 |
| Food, splanchnic blood flow, and bioavailability of drugs subject to first‐pass metabolism AJ McLean, PJ McNamara, P DuSouich, M Gibaldi, D Lalka Clinical Pharmacology & Therapeutics 24 (1), 5-10, 1978 | 180 | 1978 |
| Apparent volumes of distribution and drug binding to plasma proteins and tissues M Gibaldi, PJ McNamara European journal of clinical pharmacology 13 (5), 373-378, 1978 | 142 | 1978 |
| Entry, Half-Life, and Desferrioxamine-Accelerated Clearance of Brain Aluminum after a Single 26Al Exposure RA Yokel, SS Rhineheimer, P Sharma, D Elmore, PJ McNamara Toxicological Sciences 64 (1), 77-82, 2001 | 135 | 2001 |
| Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology SL Preston, GL Drusano, P Glue, J Nash, SK Gupta, P McNamara Antimicrobial agents and chemotherapy 43 (10), 2451-2456, 1999 | 134 | 1999 |
| Factors affecting the milk-to-plasma drug concentration ratio in lactating women: physical interactions with protein and fat JC Fleishaker, N Desai, PJ McNamara Journal of pharmaceutical sciences 76 (3), 189-193, 1987 | 124 | 1987 |
| Should TED talks be teaching us something? F Romanelli, J Cain, PJ McNamara American journal of pharmaceutical education 78 (6), 2014 | 114 | 2014 |
| Serum protein binding and the role of increased alpha 1‐acid glycoprotein in moderately obese male subjects. IH Benedek, RA Blouin, PJ McNamara British journal of clinical pharmacology 18 (6), 941-946, 1984 | 111 | 1984 |
| Endogenous accumulation products and serum protein binding in uremia PJ McNamara, D Lalka, M Gibaldi The Journal of Laboratory and Clinical Medicine 98 (5), 730-740, 1981 | 110 | 1981 |
| Evolution of Ciprofloxacin-Resistant Staphylococcus aureus in In Vitro Pharmacokinetic Environments JJ Campion, PJ McNamara, ME Evans Antimicrobial agents and chemotherapy 48 (12), 4733-4744, 2004 | 102 | 2004 |
| Effect of plasma protein and tissue binding on the biologic half‐life of drugs M Gibaldi, G Levy, PJ McNamara Clinical Pharmacology & Therapeutics 24 (1), 1-4, 1978 | 99 | 1978 |
| Serum alpha 1‐acid glycoprotein and the binding of drugs in obesity. IH Benedek, WD Fiske 3d, WO Griffen, RM Bell, RA Blouin, PJ McNamara British journal of clinical pharmacology 16 (6), 751-754, 1983 | 95 | 1983 |
| Active transport of cimetidine into human milk CY Oo, RJ Kuhn, N Desai, PJ McNamara Clinical Pharmacology & Therapeutics 58 (5), 548-555, 1995 | 94 | 1995 |
| Pharmacodynamic Modeling of Ciprofloxacin Resistance in Staphylococcus aureus JJ Campion, PJ McNamara, ME Evans Antimicrobial agents and chemotherapy 49 (1), 209-219, 2005 | 88 | 2005 |
